title: Salvage chemotherapy in recurrent head and neck cancer: the Institut Gustave Roussy experience.
authors.affiliation: Institut Gustave Roussy, Villejuif, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Armand
authors.forename: E
authors.initials: E
authors.lastname: Cvitkovic
authors.forename: G
authors.initials: G
authors.lastname: Recondo
authors.forename: P
authors.initials: P
authors.lastname: Wibault
authors.forename: G
authors.initials: G
authors.lastname: Schwaab
authors.forename: C
authors.initials: C
authors.lastname: Domenge
authors.forename: E
authors.initials: E
authors.lastname: Tellez-Bernal
authors.forename: D
authors.initials: D
authors.lastname: Gandia
authors.forename: B
authors.initials: B
authors.lastname: Luboinski
authors.forename: F
authors.initials: F
authors.lastname: Eschwege
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000145:classification / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D002945:Cisplatin / Q000627:therapeutic use*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011379:Prognosis; D016879:Salvage Therapy / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin